Articles tagged "Donors, marginal"

2022 American Transplant Congress
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
S. Iskhagi¹, R. Shahbazov¹, A. Ball¹, S. Loerzel¹, E. Shaban², B. Gallay², R. Hod Dvorai³, J. Leggat², M. Hanlon¹, R. Saidi¹
¹Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, NY, ²Department of Medicine, Division of Nephrology, SUNY Upstate Medical University, Syracuse, NY, ³Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, NY
*Purpose: The use of kidneys from deceased donors with acute kidney injury (AKI) is one of the options to expand donor pool. Several studied have…
2022 American Transplant Congress
Early Kidney Transplantation Irrespective of Donor Profile Offers Survival Benefit in Recipients Older Than 70 Years
A. Mujkanovic¹, T. Jarmi², C. B. Taner¹, K. P. Croome¹, S. A. Mao¹
¹Transplant Surgery, Mayo Clinic, Jacksonville, FL, ²Transplant Medicine, Mayo Clinic, Jacksonville, FL
*Purpose: Donor and recipient pre-transplant risk factors are known to influence post-transplant recipient survival. This study’s purpose was to identify the most important donor and…
2022 American Transplant Congress
Real World Experience Utilizing Donor Kidneys at Risk for Acute Kidney Injury with Belatacept Based Maintenance Immunosuppression
B. Sirandas, A. Chan, M. Eiting, T. Larson, C. Truax, L. Smith
University of Utah Health, Salt Lake City, UT
*Purpose: The demand for kidney transplant continues to rise, and limited supply has encouraged acceptance of marginal donor organs, such as those at risk for…
2022 American Transplant Congress
Liver Transplant Outcomes Using Grafts with Early Allograft Dysfunction
S. Y. Ohara¹, E. Macdonough², G. Mahdi³, L. Egbert³, B. Lizaola-Mayo², W. Hewitt⁴, A. Mathur⁴, A. Moss⁴, K. Reddy⁴, B. Aqel⁴, C. Jadlowiec⁴
¹Division of Surgery, Valleywise Health Medical Center, Creighton University, Phoenix, AZ, ²Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, AZ, ³Mayo Clinic Alix School of Medicine, Phoenix, AZ, ⁴Division of Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: The significance of early allograft dysfunction (EAD) and its impact on liver transplant (LT) outcomes remains debated. Our study aimed to assess LT outcomes…
2022 American Transplant Congress
Longitudinal Analysis of Donor-Derived Cell-Free DNA (dd-cfDNA) in En-Bloc Kidney Transplantation
S. K. Akkina¹, J. Klein², A. Khalil³, G. Shekhtman⁴, S. Patel⁴, N. Agrawal⁴, M. Fei⁴, N. Singh⁵, A. Desai¹
¹Loyola University Medical Center, Maywood, IL, ²University of Kansas Medical Center, Kansas City, KS, ³Dallas Nephrology Associates, Dallas, TX, ⁴CareDx, Brisbane, CA, ⁵Willis Knighton Health System, Shreveport, LA
*Purpose: The longitudinal dd-cfDNA patterns in en-bloc kidney transplant recipients have not been studied. It is unknown how the initial smaller mass of the two…
2022 American Transplant Congress
The Rise in the Number of Eligible Donors for Liver Transplantation Has Been Driven by an Exponential Increase in Marginal Donors
C. Goff¹, M. F. McDonald¹, A. Anand¹, K. Agahi¹, J. Kahla¹, A. Jang¹, B. Martin¹, Z. Shah¹, S. Stockum¹, R. Vopni², J. A. Goss¹, A. Rana¹
¹Baylor College of Medicine, Houston, TX, ²Texas Tech University Health Science Center, Lubbock, TX
*Purpose: To determine which subcategories of marginal livers have seen advancements in utilization and which have not.*Methods: 181,992 eligible donors listed in the Organ Procurement…
2022 American Transplant Congress
The Liver Regenerative Effect of Substance P After Major Hepatectomy in Rat Models
H. Ahn¹, H. Ko²
¹Surgery, Kyung Hee University, Seoul, Korea, Republic of, ²Kyung Hee University Hospital, Seoul, Korea, Republic of
*Purpose: The hepatic damages are inevitable under liver surgery. Therefore, post-hepatectomy liver failure remains one of the most dangerous and lifethreatening complications of hepatectomy. The…
2022 American Transplant Congress
Waitlisted and Transplant Patient Perspectives on Expanding Access to Deceased Donor Kidney Transplants
C. Rosaasen¹, N. Rosaasen², R. Mainra³, A. Trachtenberg⁴, J. Ho⁵, C. Parsons⁶, S. Delaney⁶, H. Mansell⁷
¹Johnson Shoyama School of Public Policy, University of Saskatchewan, Saskatoon, SK, Canada, ²Saskatchewan Transplant Program, Saskatchewan Health Authority, Saskatoon, SK, Canada, ³Division of Nephrology, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, ⁴, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁵Department of Internal Medicine and Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada, ⁶Canadian Blood Services, Edmonton, AB, Canada, ⁷University of Saskatchewan, Saskatoon, SK, Canada
*Purpose: A concerning number of kidneys (expanded donor criteria, extended criteria, or marginal kidneys) are discarded yearly, and novel solutions are needed to solve the…
2022 American Transplant Congress
Renal Allograft Outcomes of Very High KDPI vs High KDPI Donor Kidneys
R. Rattanavich, R. Villicana
Transplant Nephrology, Transplant Institute Loma Linda University, Loma Linda, CA
*Purpose: Since KDPI > 85 donor kidneys have been commonly used among older recipients, renal allograft outcomes of very high KDPI (≥95) donors have been…
2022 American Transplant Congress
The Feasibility of Changing HCC MELD Exception Criteria to an Exclusive DCD-Only Option: A Strategy to Increase DCD Utilization
G. J. McKenna, P. Schultz, M. Finotti, M. Rosenzweig, A. Gupta, S. H. Lee, A. Wall, E. Martinez, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: Outcomes of DCD liver transplantation is comparable to DBD but routine utilization of DCD liver grafts is surprisingly uneven in the US. A more…

« Previous Page
1
…
4
5
6
7
8
…
29
Next Page »